ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

VYX vs DBD // GROSS PROFIT MARGIN

NCR Voyix Corporation (NYSE) VS. Diebold Nixdorf Incorporated (NYSE) • 15-METRIC TALLY: VYX 2 — DBD 9
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (VYX VS. DBD) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC VYX DBD SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin ACTIVE — 25.30% — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) 1.10% 11.50% -10.40 DBD /roic <GO>
EV/EBITDA & P/E Valuation 77.1x 10.6x +66.50 DBD /valuation <GO>
Free Cash Flow Yield -18.50% 15.14% -33.64 DBD /fcf-yield <GO>
Operating Margin 1.00% 6.40% -5.40 DBD /operating-margins <GO>
Net Profit Margin 2.30% 2.50% -0.20 DBD /net-margins <GO>
Revenue Growth (YoY) -4.60% 1.50% -6.10 DBD /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity 1.16 1.79 -0.63 DBD /balance-sheet <GO>
Piotroski F-Score Quality 2/9 8/9 -6.00 DBD /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 56.4 39.3 +17.10 VYX /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple 17.0x 19.5x -2.50 VYX /forward-pe <GO>
Enterprise Scale & Market Cap $1.13B $1.99B -$851.4M DBD /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR VYX REV DBD REV VYX GROSS % DBD GROSS % VYX FCF DBD FCF
FY 2025 $2.69B $3.81B — 25.3% -$210.0M $300.7M
FY 2024 $2.82B $3.75B — 24.5% -$162.0M $149.2M
FY 2023 $3.17B — — — $694.0M —
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
VYX // BETA —
DBD // BETA —